In different in vitro AD models, both compounds showed to prevent Aβ fibrils formation and cytotoxicity [155,156,157,158], and rutin was identified as a BACE-1 inhibitor that specifically prevents APP cleavage, decreasing production of the sAPPβ fragment [155,159,160]. Here, APP is linked to Alzheimer disease.